Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03509246
Brief Title: Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients

First Submitted : March 29, 2018
First Submitted that Met QC Criteria : April 25, 2018
First Posted : April 26, 2018

Last Update Submitted that Met QC Criteria : January 12, 2020
Last Update Posted : January 14, 2020